{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:05Z","timestamp":1767135125956,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009826","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:00:00Z","timestamp":1390780800000}}],"reference-count":26,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009826.pub2","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:32:00Z","timestamp":1390782720000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of Kaposi sarcoma in children with HIV-1 infection"],"prefix":"10.1002","volume":"2014","author":[{"given":"Andrew","family":"Anglemyer","sequence":"first","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; San Francisco California USA 94105"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag K","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Children's Hospital and Research Center Oakland; Oncology; 747 52nd Street Oakland California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W","family":"Rutherford","sequence":"additional","affiliation":[{"name":"University of California, San Francisco; Global Health Sciences; San Francisco California USA 94105"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"10.1002\/14651858.CD009826.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/pbc.24516","article-title":"Clinical Characteristics and Outcomes of HIV-Infected Children Diagnosed with Kaposi Sarcoma in Malawi and Botswana","volume":"60","author":"Cox","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1002\/14651858.CD009826.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/pbc.22369","article-title":"Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children","volume":"54","author":"Gantt","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1002\/14651858.CD009826.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/pbc.22903","article-title":"Kaposi sarcoma in South African Children","volume":"56","author":"Stefan","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1002\/14651858.CD009826.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/INF.0b013e318228fb04","article-title":"Treatment of Kaposi sarcoma in human immunodeficiency virus-1 infected Mozambican children with antiretroviral drugs and chemotherapy","volume":"30","author":"Vaz","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0005|cit5","first-page":"385","article-title":"Management of AIDS-Associated Kaposi's Sarcoma in Nigerian Children: A Case Series and Review of Literature","volume":"104","author":"Ahmed","year":"2012","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"10.1002\/14651858.CD009826.pub2-BIB0006|cit6","first-page":"143","article-title":"Use of thalidomide in the management of three HIV seroreactive children with Kaposi's sarcoma referred for palliative care","volume":"20","author":"Bunn","year":"2008","journal-title":"Malawi Med J"},{"issue":"5","key":"10.1002\/14651858.CD009826.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/pbc.22412","article-title":"Kaposi sarcoma: the African HIV epidemic's partner in crime","volume":"54","author":"Davidson","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1002\/14651858.CD009826.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/00002030-199906180-00026","article-title":"Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy.","volume":"13","author":"Niehues","year":"1999","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0010|cit10","article-title":"Prospective Stage-Stratified Approach to AIDS-Related Kaposi's Sarcoma","volume":"doi 10.1200\/JCO","author":"Bower","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1002\/14651858.CD009826.pub2-BIB0011|cit11","first-page":"779","article-title":"Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy","volume":"27","author":"Cattelan","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1634\/theoncologist.12-1-114","article-title":"A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma","volume":"12","author":"Cooley","year":"2007","journal-title":"Oncologist"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(07)70036-0","article-title":"Management of AIDS-related Kaposi's sarcoma","volume":"8","author":"Lorenzo","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0014|cit14","unstructured":"Shuenemann H Brozek J Oxman A GRADE Working Group 2008"},{"issue":"7650","key":"10.1002\/14651858.CD009826.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0016|cit16","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/jmv.20952","article-title":"Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV\/AIDS endemic region","volume":"79","author":"Kasolo","year":"2007","journal-title":"J Med Virol"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's Sarcoma in the Acquired Immune Deficiency Syndrome:A Proposal for Uniform Evaluation, Response,and Staging Criteria","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/157016209789973619","article-title":"AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies","volume":"7","author":"Martellotta","year":"2009","journal-title":"Curr HIV Res"},{"issue":"12","key":"10.1002\/14651858.CD009826.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.aids.0000131385.60974.b9","article-title":"Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma","volume":"18","author":"Martin-Carbonero","year":"2004","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jmv.10548","article-title":"Comparison of human herpesvirus-8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma","volume":"72","author":"Martro","year":"2004","journal-title":"J Med Virol"},{"issue":"4","key":"10.1002\/14651858.CD009826.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pbc.24408","article-title":"The management of children with Kaposi sarcoma in resource limited settings","volume":"60","author":"Molyneux","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1002\/14651858.CD009826.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","article-title":"A randomized controlled trial of HAART versus HAART and chemotherapy in therapy-na\u00efve patients with HIV-associated Kaposi sarcoma in South Africa","volume":"60","author":"Mosam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0024|cit24","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"issue":"5","key":"10.1002\/14651858.CD009826.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3111\/13696998.2013.777347","article-title":"Cost effectiveness of liposomal doxorubicin vs paclitaxel for the treatment of advanced AIDS-Kaposi's sarcoma","volume":"16","author":"Raimundo","year":"2013","journal-title":"J Med Econ"},{"key":"10.1002\/14651858.CD009826.pub2-BIB0026|cit26","first-page":"50","article-title":"HHV-8 infection in African children","volume":"11","author":"Sarmati","year":"2004","journal-title":"Herpes"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009826.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T05:47:34Z","timestamp":1719208054000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009826.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009826.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,27]]}}}